Alector (ALEC)

• Market cap: $217M
• 1 day: -1%
• 5 days: 4.74%
• 1 month: 8.74%
• 3 months: 65.83%
• 6 months: -9.55%
• Year to date: 30.07%
• 1 year: 6.99%
• 5 years: -88.44%
• 10 years: -88.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Employees: 156